Hypofibrinogenemia, Congenital
Also known as: Congenital Hypofibrinogenemia / Hereditary deficiency of other clotting factors / Congenital afibrinogenaemia / Congenital hypofibrinogenemia (disorder) / Congenital Afibrinogenemia / Congenital hypofibrinogenaemia / Hereditary factor I deficiency disease (disorder) / Factor I deficiency / Deficiency factor I / Fibrinogen deficiency (disorder) / Deficiency, Fibrinogen
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09222 | Fibrinogen human | A hemostatic agent used for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. |
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09222 | Fibrinogen human | 2 / 3 | Completed | 1 |
| DB09222 | Fibrinogen human | 3 | Completed | 1 |